Loading…
Loading…
Just curious if that's already in hand for 2Q, or something that's still being recouped? And then any color on margin impact that would have had in the quarter
Can you just give a little bit more color on the cadence from here in the bridge to that improvement after being down a little bit in 1Q?
Did China's anti-involution campaign have an impact on the business over there
Curious how conversations there, particularly among pharma customers have evolved in the past 45 days or so with commentary getting better around MFN